Tengjun Biotechnology Corp. (OTC: TJBH)

This investigation is for anyone who acquired securities in Tengjun Biotechnology Corp. (OTC: TJBH) prior to September 5, 2023.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company had in place proper controls to account for expenses correctly but then by having to restate the Company’s financial statements for the Company’s fiscal year ended December 31, 2022 .

On September 5, 2023, Tengjun disclosed that its previously issued financial statements for the fiscal year ended December 31, 2022 should “no longer be relied upon due to accounting methodology errors” and that it plans to restate its financial statements by amending its annual report on Form 10-K for the fiscal year ended December 31, 2022 “as soon as reasonably practicable.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Tengjun Biotechnology Corp. (OTC: TJBH) prior to September 5, 2023 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.